Cargando…
Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy
Consistent standards regarding whether postoperative adjuvant chemotherapy is required in the treatment of adenoid cystic carcinoma of the breast (ACCB) are currently lacking. Using clinical data from the Surveillance, Epidemiology, and End Results (SEER) database (1988–2015), and the National Cance...
Autores principales: | Li, Lixi, Zhang, Di, Ma, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369505/ https://www.ncbi.nlm.nih.gov/pubmed/35956093 http://dx.doi.org/10.3390/jcm11154477 |
Ejemplares similares
-
Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast
por: Zhang, Di, et al.
Publicado: (2022) -
Adenoid cystic carcinoma of the breast
por: Thomas, Devon N, et al.
Publicado: (2019) -
Male Adenoid Cystic Carcinoma of the Breast
por: Li, Jie Xiao, et al.
Publicado: (2021) -
Male Breast Adenoid Cystic Carcinoma
por: Yoo, Seung Jin, et al.
Publicado: (2013) -
The prognostic value of chemotherapy or/and radiotherapy in adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix
por: Liu, Kun, et al.
Publicado: (2022)